These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35267614)

  • 1. Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe.
    Berdel WE
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials].
    Dreier G; Marx C; Schmoor C; Maier-Lenz H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):445-52. PubMed ID: 15830256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
    Georgias C; Grunow A; Olderog M; May A; Paulus U
    Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic principles, planning and implementation of non-commercial clinical trials].
    Finger RP; Coch C; Coenen M; Mengel M; Hartmann G; Holz FG
    Ophthalmologe; 2011 Jan; 108(1):25-32. PubMed ID: 21181167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Challenges in the organization of investigator initiated trials: in transplantation medicine].
    Schnitzbauer AA; Lamby PE; Mutzbauer I; von Hassel J; Geissler EK; Schlitt HJ
    Chirurg; 2011 Mar; 82(3):249-54. PubMed ID: 21416397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
    Kölch M; Lippert HD; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law].
    Benninger-Döring G; Boos J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jul; 49(7):675-80. PubMed ID: 16763801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GCP inspections in Germany and Europe following the implementation of the Directive 2001/20/EC.
    Göbel C; Baier D; Ruhfus B; Hundt F
    Ger Med Sci; 2009 Mar; 7():Doc01. PubMed ID: 19675741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consequences of the 12th AMG amendment on the conduct of non-commercial clinical trials].
    Rossion I
    Urologe A; 2005 Dec; 44(12):1444-8. PubMed ID: 16283155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First experiences with the implementation of EU Regulation 536/2014 (CTR) from the perspective of non-commercial academic research].
    Fuhrmann C; Reineke C; Lang B; Grählert X
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):38-44. PubMed ID: 36525036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials].
    Ihrig K; Fath B; Fuchs M; Hallek M; Marschner N; Naumann R; Röllig C; Saussele S; Tesch H; Gökbuget N
    Onkologie; 2013; 36 Suppl 2():23-8. PubMed ID: 23549033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of national legislation and practice on clinical trials with vulnerable patients based on the EU Clinical Trials Directive by the example of adults permanently incapable of giving informed consent.
    Schweim JK; Nonnemacher M; Jöckel KH
    Ger Med Sci; 2021; 19():Doc03. PubMed ID: 33796001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
    Ito T
    PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of the 1st meeting of the "Vienna Initiative to Save European Academic Research (VISAER)".
    Druml C; Singer EA; Wolzt M
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):Suppl 1-12. PubMed ID: 16783888
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.